By PE Edge Editorial Staff Hodes Weill & Associates and Cornell University published their annual Institutional Real Estate Allocations Monitor on real estate in institutional portfolios and the effects of institutional allocation tendencies on the investment management sector. The study...

By Exec Edge Editorial Staff Iran’s interference in Iraq’s internal politics has been pernicious and growing since the fall of Saddam Hussein in 2003. The Council on Foreign Relations writes that Iran has ties to more than a dozen political...

    By Healthcare Edge Editorial Staff Octave Bioscience, Inc., a company offering treatment for multiple sclerosis and other neurodegenerative diseases, said it has received a $10 million grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF). The...

  By Karen E. Roman SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage company developing a fully-human treatment to delay the progress of type 1 diabetes, said its net loss narrowed in the third quarter. The net loss was $5.1 million,...

By Thomas S. Green Swiss athletic brand On Holding AG (NYSE: ONON) raised full-year sales guidance after posting another record quarter, boosted by strength in footwear, apparel and accessories. The Zurich-based company said net sales rose 46.5% to CHF 480.5...

The leading provider of AI-powered enterprise communications software is unlocking the true value of contact centers with the GA release of RingCX By Exec Edge Editorial Staff RingCentral, the trailblazer in AI-powered global enterprise cloud communications, has opened the doors...

  By Karen E. Roman Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a company which develops biologic medicines, announced it has appointed Dorothy Clarke to its board of directors. Ms. Clarke previously held leadership roles at Johnson & Johnson for...

By Karen E. Roman Alladapt Immunotherapeutics, Inc., a clinical-stage company which develops therapeutics to address food allergies, announced data from its Phase 1/2 Harmony study which proves that ADP101, a multi-allergen oral immunotherapy (OIT), produced dose-dependent, clinically meaningful responses. The...

  IPO Edge and the Palm Beach Hedge Fund Association will host a fireside chat with Live Ventures (Nasdaq: LIVE) on Nov. 13 at 2 pm ET. The live event will feature Jon Isaac, President and Chief Executive Officer, Live Ventures, moderated...

By John Jannarone Shares of Direct Digital Holdings, Inc. (Nasdaq: DRCT) surged as much as 50% Friday morning after the company raised guidance and multiple brokers announced higher price targets on the stock. Direct Digital Holdings, which brings together media...